Vice President, Head of Portfolio & Program Strategy Greater Seattle, WA Area

The Company is seeking a Vice President, Head of Portfolio & Program Strategy to play a pivotal role in the strategic and operational leadership of its portfolio and program management function. The successful candidate will be a key partner to the executive team, driving enterprise-level portfolio strategy in alignment with scientific, clinical, operational, and commercial objectives. This leadership position requires a deep understanding of the end-to-end drug development process and a proven track record in leading programs through clinical development. The role involves establishing and maintaining a clear portfolio view, leading portfolio prioritization and investment discussions, and ensuring integrated decision-making across the organization. The ideal candidate will have a Bachelor's degree in a relevant field, with at least 15 years of experience in the biotechnology or pharmaceutical industry, and a strong background in portfolio and program management. Key responsibilities for the Vice President, Head of Portfolio & Program Strategy include team and organizational leadership, strategic planning, and fostering a culture of transparency, collaboration, and operational excellence. The role demands exceptional leadership and coaching capabilities, as well as the ability to influence and align stakeholders at all levels. The candidate should be adept at balancing urgency with realistic, executable program plans, and have a proven ability to manage risks, resources, and capacity effectively. A preferred qualification is an advanced degree in a related discipline, and experience in scaling a portfolio and program management function within a growth-stage biotechnology company. The position is critical for the company's mission to develop innovative therapies and requires a leader who is passionate about the challenges of cutting-edge drug development and is committed to the values and principles that support the overall mission.

Hiring Company

Umoja BioPharma